IBRX
ImmunityBio·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-21
Latest data update time: Updated on 2026-03-21
6.69 / 10Overall Score
OutperformInvestment Rating
6.69 / 10Overall Score
OutperformInvestment Rating
Is IBRX a Good Buy Right Now?
- Based on a composite score of 6.69/10, we rate IBRX as a Outperform. Our analysis breaks down into 0.89/10 for Fundamentals, 6.07/10 for Technicals, and 9.90/10 for Sentiment, indicating the stock is likely to See further upside.
Technical Analysis of IBRX?
Is IBRX undervalued or overvalued?
What is the analyst consensus for IBRX?
Is IBRX a Good Buy Right Now?
- Based on a composite score of 6.69/10, we rate IBRX as a Outperform. Our analysis breaks down into 0.89/10 for Fundamentals, 6.07/10 for Technicals, and 9.90/10 for Sentiment, indicating the stock is likely to See further upside.
Is IBRX undervalued or overvalued?
Technical Analysis of IBRX?
What is the analyst consensus for IBRX?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
